Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
126.1 USD | -2.65% | -3.67% | +15.54% |
02:30pm | Merck: positive results for Keytruda in breast cancer | CF |
01:48pm | Merck Says Phase 3 Trial of Keytruda in Triple Negative Breast Cancer Met Overall Survival Endpoint | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.61% | 328B | |
+37.75% | 727B | |
-7.88% | 354B | |
-0.41% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.83% | 164B | |
-2.03% | 164B | |
-1.31% | 122B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Transcript : Merck & Co., Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 04